Precigen PGEN
NASDAQ PGEN
$7.11 -0.03 (-0.49%)
As of: Sep 4, 2026 · 3:59 PM EDT

Precigen (PGEN) Retained Earnings (2012 - 2026)

Precigen (PGEN) posted quarterly Retained Earnings of -$17000.0 for Q1 2026, up 100.0% year-over-year from -$8500.0 in Q1 2025, and down 100.0% quarter-over-quarter from $2.4 billion in Q4 2025.

Analysis

Precigen (PGEN) Retained Earnings (2012 - 2026) Analysis & Trends

Precigen (PGEN) has reported Retained Earnings for 15 consecutive years, with -$17000.0 the latest figure, recorded in Q1 2026.

  • In Q1 2026, Retained Earnings rose 100.0% year-over-year to -$17000.0; the TTM figure through Mar 2026 stood at -$17000.0 (up 100.0% YoY), while the FY2025 annual figure was $2.4 billion, up 19685333.33% from the prior year.
  • Retained Earnings slipped to -$17000.0 in Q1 2026 per PGEN's latest filing, from $2.4 billion in the prior quarter.
  • Across five years, Retained Earnings topped out at $2.4 billion in Q4 2025 and bottomed at -$2.1 billion in Q1 2025.
  • Historically, Retained Earnings has averaged $410.3 million across 5 years, with a median of -$17000.0 in 2026.
  • Annual changes were most pronounced in 2024 — Retained Earnings slumped 73564.65% — and 2025, when it jumped 19685333.33%.
  • Precigen's Retained Earnings stood at -$3.5 million in 2022, then surged by 59873.97% to $2.1 billion in 2023, then tumbled by 100.0% to $12000.0 in 2024, then surged by 19685333.33% to $2.4 billion in 2025, then plunged by 100.0% to -$17000.0 in 2026.
  • Business Quant data shows PGEN's Retained Earnings at -$17000.0 in Q1 2026, $2.4 billion in Q4 2025, and $2.4 billion in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Retained Earnings (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 15.69 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 37.62 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn 558.00 Mn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 5.10 Bn
5 Revolution Medicines 44.33 Bn 44.33 Bn - -4.00 Bn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 13.05 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn -6.33 Bn
8 Royalty Pharma 28.45 Bn 27.61 Bn - 4.38 Bn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 6.57 Bn
10 Precigen 2.53 Bn 2.53 Bn 52.17 Mn 2.37 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 2.37 Bn
Mar 31, 2026 2.37 Bn
Dec 31, 2025 2.36 Bn
Sep 30, 2025 2.36 Bn
Jun 30, 2025 -2.17 Bn
Mar 31, 2025 -2.14 Bn
Dec 31, 2024 2.13 Bn
Sep 30, 2024 2.13 Bn
Jun 30, 2024 2.09 Bn
Mar 31, 2024 2.09 Bn
Dec 31, 2023 2.08 Bn
Sep 30, 2023 2.08 Bn
Jun 30, 2023 2.08 Bn
Mar 31, 2023 2.08 Bn
Dec 31, 2022 2.00 Bn
Sep 30, 2022 2.00 Bn
Jun 30, 2022 1.99 Bn
Mar 31, 2022 1.99 Bn
Dec 31, 2021 2.02 Bn
Sep 30, 2021 2.02 Bn